Anti-Human CD262 Recombinant Antibody(Lexatumumab)
-
产品编号
YR1118
-
别名
科研级 Lexatumumab ( 来沙木单抗 ), Anti-CD262 Recombinant Antibody, Research Grade Lexatumumab
-
规格
- 1mg
- 5mg
| Catalog Number | YR1118 |
| Alias | 科研级 Lexatumumab ( 来沙木单抗 ), Anti-CD262 Recombinant Antibody, Research Grade Lexatumumab |
| Size | 1mg, 5mg |
| Molecular Name | Lexatumumab |
| CAS Number | 845816-02-6 |
| Target | CD262[Homo sapiens] |
| Antibody Isotype | IgG1 Lambda |
| Clonity | Monoclonal |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.5 |
| Shipping Condition | Shipped on ice packs. |
| Background | Lexatumumab (also known as ETR2-ST01) is an experimental agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2), intended for the treatment of cancer. HGS-ETR2 antibodies were generated by Human Genome Sciences through a collaboration with Cambridge Antibody Technology. Development was discontinued in 2015. |
| Application | ELISA, IP, FCM, FuncS, Neut, IF |
| Remarks | This product is for research use only. |
0